Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599827
What this trial is testing
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
Who this might be right for
Rectal Cancer
Shanghai Zhongshan Hospital 54